What one share of Cartesian Therapeutics holds
The Company (formerly known as Selecta Biosciences, Inc., or Selecta) was incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland.
Cartesian Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.05 |
|---|---|
| Profit | −$5.61 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$2.90 |
| Cash and investments | $4.91 |
| Debt | $1.76 |
| Book value | −$4.17 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | $43.62 | −$234.93 | $3.26 | −$185.29 | — | −$1,259 |
| 2015 | $83.86 | −$453.52 | $16.22 | −$329.60 | — | −$1,608 |
| 2016 | $23.11 | −$116.57 | $1.68 | −$58.16 | — | $89.42 |
| 2017 | $0.30 | −$95.94 | $1.08 | −$77.49 | — | $69.57 |
| 2018 | $1.21 | −$87.55 | $1.18 | −$80.46 | — | −$7.23 |
| 2019 | $4.40 | −$36.46 | $0.03 | −$33.91 | — | $2.92 |
| 2020 | $4.92 | −$20.42 | $0.24 | $10.10 | — | −$5.00 |
| 2021 | $22.32 | −$6.74 | $0.28 | −$16.13 | — | $5.47 |
| 2022 | $22.78 | $2.98 | $0.25 | −$6.75 | — | $18.39 |
| 2023 | $5.03 | −$49.76 | $0.04 | −$9.94 | — | −$81.55 |
| 2024 | $2.24 | −$4.49 | $0.52 | −$1.89 | — | −$0.26 |
| 2025 | $0.11 | −$5.02 | $0.21 | −$3.06 | — | −$4.85 |
Common questions about Cartesian Therapeutics
How much does one share of Cartesian Therapeutics earn?
Over the last 12 months, Cartesian Therapeutics lost $5.61 for each share on $0.05 of sales.
Does Cartesian Therapeutics pay a dividend?
Cartesian Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cartesian Therapeutics’s book value per share?
Cartesian Therapeutics’s book value is negative (−$4.17 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Cartesian Therapeutics have?
Each share of Cartesian Therapeutics has $4.91 of cash and investments and $1.76 of debt, as of June 30, 2026.
What is Cartesian Therapeutics’s free cash flow per share?
−$2.90 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Cartesian Therapeutics bought back shares?
Cartesian Therapeutics’s share count rose about 37170% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.